Lecap Asset Management Ltd. Sells 58,941 Shares of Bath & Body Works, Inc. $BBWI

Lecap Asset Management Ltd. lessened its holdings in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 55.3% during the 2nd quarter, Holdings Channel reports. The firm owned 47,688 shares of the company’s stock after selling 58,941 shares during the period. Lecap Asset Management Ltd.’s holdings in Bath & Body Works were worth $1,429,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Victory Capital Management Inc. boosted its holdings in Bath & Body Works by 14,732.0% during the 1st quarter. Victory Capital Management Inc. now owns 6,798,108 shares of the company’s stock valued at $206,119,000 after acquiring an additional 6,752,274 shares during the period. AQR Capital Management LLC boosted its position in Bath & Body Works by 267.8% during the first quarter. AQR Capital Management LLC now owns 3,993,173 shares of the company’s stock worth $121,073,000 after purchasing an additional 2,907,506 shares in the last quarter. Fuller & Thaler Asset Management Inc. raised its holdings in shares of Bath & Body Works by 115.7% during the first quarter. Fuller & Thaler Asset Management Inc. now owns 3,680,104 shares of the company’s stock valued at $111,581,000 after acquiring an additional 1,973,679 shares during the last quarter. Assenagon Asset Management S.A. lifted its position in Bath & Body Works by 3,642.2% during the first quarter. Assenagon Asset Management S.A. now owns 1,651,109 shares of the company’s stock worth $50,062,000 after buying an additional 1,606,988 shares in the last quarter. Finally, T. Rowe Price Investment Management Inc. increased its stake in Bath & Body Works by 7.6% during the first quarter. T. Rowe Price Investment Management Inc. now owns 11,016,767 shares of the company’s stock worth $334,029,000 after acquiring an additional 781,681 shares during the last quarter. Hedge funds and other institutional investors own 95.14% of the company’s stock.

Bath & Body Works Stock Performance

Shares of BBWI stock opened at $25.66 on Thursday. The firm’s 50 day moving average price is $28.65 and its two-hundred day moving average price is $29.53. The stock has a market cap of $5.29 billion, a PE ratio of 7.61, a PEG ratio of 0.88 and a beta of 1.52. Bath & Body Works, Inc. has a 52-week low of $24.93 and a 52-week high of $41.87.

Bath & Body Works (NYSE:BBWI) last issued its quarterly earnings data on Thursday, August 28th. The company reported $0.37 EPS for the quarter, hitting analysts’ consensus estimates of $0.37. The business had revenue of $1.55 billion for the quarter, compared to analyst estimates of $1.55 billion. Bath & Body Works had a net margin of 9.88% and a negative return on equity of 48.43%. The firm’s quarterly revenue was down .8% on a year-over-year basis. During the same period last year, the business posted $0.37 earnings per share. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. As a group, sell-side analysts predict that Bath & Body Works, Inc. will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, September 5th. Stockholders of record on Friday, August 22nd were given a $0.20 dividend. The ex-dividend date was Friday, August 22nd. This represents a $0.80 annualized dividend and a dividend yield of 3.1%. Bath & Body Works’s payout ratio is presently 23.74%.

Analyst Ratings Changes

BBWI has been the subject of a number of research analyst reports. Telsey Advisory Group reissued an “outperform” rating and issued a $38.00 target price on shares of Bath & Body Works in a research report on Thursday, August 28th. Wall Street Zen cut Bath & Body Works from a “buy” rating to a “hold” rating in a report on Saturday, August 9th. UBS Group cut their target price on Bath & Body Works from $36.00 to $32.00 and set a “neutral” rating on the stock in a research report on Friday, August 29th. Citigroup dropped their target price on Bath & Body Works from $42.00 to $40.00 and set a “buy” rating on the stock in a research report on Tuesday, August 19th. Finally, JPMorgan Chase & Co. lifted their target price on Bath & Body Works from $40.00 to $46.00 and gave the company an “overweight” rating in a research note on Monday, July 28th. Twelve investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $39.69.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.